Pharmaceuticals
In a recent study it was found that the top of mind challenges that Bio/Pharma organizations are grappling with are the regulatory risks of post approval post market surveillance, privacy, assessing adverse drug reactions (ADR's) ie Pharmacovigilance, reduction of redundant regulatory efforts and compliance related training.
Other challenges faced today include:
It is in this environement that the risk and compliance officers need to operate effectively and efficiently. The challenges posed lead the risk and compliance function to require solutions that will:
Cura's Enterprise GRC Platform has been developed to assist customers achieve their strategic objectives and maintain advantage in this highly regulated environment. Cura's proven success in the sector includes customers such as Johnson & Johnson, GlaxoSmithKline, Eli Lilly, and Health Services Australia.
Cura will assist your organization in:
Related Information:
To find out more about Cura's capabilities in this sector, please contact us .
Copyright 2010 Cura Software Solutions. All rights reserved. Privacy Statement. Legal Notice.